Your browser doesn't support javascript.
The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada.
Brown, Kevin A; Soucy, Jean-Paul R; Buchan, Sarah A; Sturrock, Shelby L; Berry, Isha; Stall, Nathan M; Jüni, Peter; Ghasemi, Amir; Gibb, Nicholas; MacFadden, Derek R; Daneman, Nick.
  • Brown KA; Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael's Hospital (Jüni); Si
  • Soucy JR; Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael's Hospital (Jüni); Si
  • Buchan SA; Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael's Hospital (Jüni); Si
  • Sturrock SL; Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael's Hospital (Jüni); Si
  • Berry I; Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael's Hospital (Jüni); Si
  • Stall NM; Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael's Hospital (Jüni); Si
  • Jüni P; Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael's Hospital (Jüni); Si
  • Ghasemi A; Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael's Hospital (Jüni); Si
  • Gibb N; Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael's Hospital (Jüni); Si
  • MacFadden DR; Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael's Hospital (Jüni); Si
  • Daneman N; Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael's Hospital (Jüni); Si
CMAJ ; 193(17): E592-E600, 2021 04 26.
Article in English | MEDLINE | ID: covidwho-1207650
ABSTRACT

BACKGROUND:

Nonpharmaceutical interventions remain the primary means of controlling severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) until vaccination coverage is sufficient to achieve herd immunity. We used anonymized smartphone mobility measures to quantify the mobility level needed to control SARS-CoV-2 (i.e., mobility threshold), and the difference relative to the observed mobility level (i.e., mobility gap).

METHODS:

We conducted a time-series study of the weekly incidence of SARS-CoV-2 in Canada from Mar. 15, 2020, to Mar. 6, 2021. The outcome was weekly growth rate, defined as the ratio of cases in a given week versus the previous week. We evaluated the effects of average time spent outside the home in the previous 3 weeks using a log-normal regression model, accounting for province, week and mean temperature. We calculated the SARS-CoV-2 mobility threshold and gap.

RESULTS:

Across the 51-week study period, a total of 888 751 people were infected with SARS-CoV-2. Each 10% increase in the mobility gap was associated with a 25% increase in the SARS-CoV-2 weekly case growth rate (ratio 1.25, 95% confidence interval 1.20-1.29). Compared to the prepandemic baseline mobility of 100%, the mobility threshold was highest in the summer (69%; interquartile range [IQR] 67%-70%), and dropped to 54% in winter 2021 (IQR 52%-55%); a mobility gap was present in Canada from July 2020 until the last week of December 2020.

INTERPRETATION:

Mobility strongly and consistently predicts weekly case growth, and low levels of mobility are needed to control SARS-CoV-2 through spring 2021. Mobility measures from anonymized smartphone data can be used to guide provincial and regional loosening and tightening of physical distancing measures.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Disease Transmission, Infectious / COVID-19 Testing / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Female / Humans / Male Country/Region as subject: North America Language: English Journal: CMAJ Journal subject: Medicine Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Disease Transmission, Infectious / COVID-19 Testing / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Female / Humans / Male Country/Region as subject: North America Language: English Journal: CMAJ Journal subject: Medicine Year: 2021 Document Type: Article